ArticleJHEP reports : innovation in hepatology2023

Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies.

Georgia Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.